Research and development contract, proposal JW210398 titled "further development of 5-AED (androstenediol, neumune) for the protection from acute radiation syndrome (ARS)," on behalf of…

Active Definitive Contract Awarded Last action

Contract number
W81XWH22C0126
Awardee
Awarding agency
Obligated
$4,500,000

Award facts

Contract value 100% obligated
$4,500,000.00 Current and potential, with all options
Completion date 96% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost No Fee
Place of performance
Omaha, NE 68198, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 $0
Change Order P00003 · Conduct research into manufacturing of items regarding how to protect warfighter and other individuals against ionizing radiation and mitigate acute radiation… $0
Supplemental Agreement for work within scope P00002 · Further development of 5-androstenediol, neumune for the protection from acute radiation syndrome $0
Other Administrative Action P00001 · Per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/1/2022. R & d contract/proposal JW210398 "further development of 5-AED (androstenediol, neumune)… $0
Original award $4,500,000

About this award

This federal contract award is for a research and development effort focused on the further development of 5-AED (androstenediol, neumune) for protection against acute radiation syndrome (ARS). The contract, valued at $4,500,000.00, was awarded by the Defense Health Agency to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division. The contract has a period of performance through December 18, 2026. This effort is being conducted under a definitive contract with cost-no-fee pricing. No set-aside designation was used for this award. The Board of Regents of the University of Nebraska has demonstrated extensive capabilities in providing federal research and development services, particularly in the areas of medical innovation and military medical research. The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. is a major subcontractor on this effort, bringing specialized expertise in military medical research and development.

Description

Research and development contract, proposal JW210398 titled "further development of 5-AED (androstenediol, neumune) for the protection from acute radiation syndrome (ARS)," on behalf of congressionally directed medical research programs

Subawards

Subcontractor Amount Awarded
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. FURTHER DEVELOPMENT OF 5-ANDROSTENEDIOL, NEUMUNE FOR THE PROTECTION FROM ACUTE RADIATION SYNDROME Further development of 5-AED (androstenediol, Neumune) for the… $1,559,433

Quick answers

Who was awarded contract W81XWH22C0126?

W81XWH22C0126 was awarded to Board Of Regents Of The University Of Nebraska by Defense Health Agency (Department of Defense) on September 19, 2022.

How much is contract W81XWH22C0126 worth?

The government has obligated $4,500,000 on W81XWH22C0126.

Was contract W81XWH22C0126 competed?

The extent of competition for W81XWH22C0126 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award